Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
TLR7/8 Inhibitor Reduces Cutaneous Disease Activity in SLE
May 2026
Researchers reported significant dose-dependent improvements in lupus skin disease activity with the oral TLR7/8 inhibitor enpatoran.
Read more
12 Jun 2024
Prediagnostic Proteomics of Gout: Abstracts from EULAR 2024
A study presented at EULAR 2024 aimed to investigate the relationship between large-scale pre-diagnostic proteomics and the risk of incident gout in a nationwide prospective cohort.
12 Jun 2024
Anti-Ro/SSA Antibodies in Systemic Sclerosis Stratification: Abstracts from EULAR 2024
Research presented at EULAR 2024 aimed to evaluate the prevalence of anti-Ro/SSA antibodies in the largest available cohort of established systemic sclerosis patients.
4 Jun 2024
Early Diagnosis Crucial for Better Outcomes in Psoriatic Arthritis
A recent study highlights the importance of early diagnosis in psoriatic arthritis patients, showing that shorter delays lead to better clinical outcomes.
4 Jun 2024
Sex-Based Differences in axSpA Treatment Response
Recent study highlights sex differences in disease activity measures and treatment responses among patients with axial spondylarthritis
23 May 2024
Blood Test Predicts Knee Osteoarthritis 8 Years Earlier
A new blood test has successfully predicted risk of knee osteoarthritis eight years before signs of the disease appeared on X-rays.
23 May 2024
Connection Between Arthritis and Blood Cancer Mutations
Researches have found a link between rheumatoid arthritis and certain gene mutations found in cancer.
11 May 2024
Rheumatoid Arthritis Treatment Linked with Lower Dementia Risk
A new study found that, among patients with rheumatoid arthritis who are treated with biologic disease-modifying antirheumatic drugs, dementia risk is decreased.
11 May 2024
Weight-Bearing Activity Tied to Knee Osteoarthritis Risk
According to recent findings, a weight-bearing activity could contribute to increased odds of radiographic knee osteoarthritis in people with low levels of lower-limb muscle mass.
Loading posts...
« Previous
1
…
27
28
29
30
31
…
44
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View